Company intelligence / Profile preview

BioTek reMEDys

New Castle, Delaware, United Statesbiotekrx.com ↗

Ownership: Private
Development stage: Commercial

Overview

BioTek reMEDys provides integrated infusion therapy and specialty pharmacy services for patients with rare diseases and chronic conditions. The company offers high-touch therapies including biologics/biotherapeutics and pharmaceuticals through home infusion services nationwide. It does not conduct clinical trials or develop proprietary therapeutics.

Therapeutic areas: OtherRare Diseases
Modalities: BiologicSmall moleculePharmaceuticalBiotherapeutic
Industry: Non-Academic Healthcare

Partnerships

National Association of Specialty Pharmacy (NASP) member

Beyond the preview

Go deeper on BioTek reMEDys.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BioTek reMEDys.

Explore the full profile